EquiRab® with Havlogen® is a killed rabies virus vaccine for use in healthy horses, 4 months of age or older as an aid in preventing disease due to rabies virus up to 14 months following vaccination. Prevents disease caused by rabies virus Effective up to 14 months following vaccination Contains Neomycin and Polymixin B For vaccination of healthy horses 4 months of age or older
Equirab is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.
EquiRab® with Havlogen® is a rabies vaccine for use in horses, 4 months of age or older. For primary vaccination aspectically administer 1 ml intramuscularly. Annual revaccination is recommended. A boster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidermic conditions exist or are reported. Consult your veterinarian.
Storage: Store at 2° - 7° F (35° - 45° F).
Cautions For animal use only. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactic reactions may occur. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs. Consult a veterinarian before administering vaccines.